1. Inicio
  2. Proyectos y Estudios
  3. A randomized, placebo-controlled, double-blind Phase 3 study to evaluate the efficacy, safety and tolerability of votoplam in participants with Huntington’s Disease.

A randomized, placebo-controlled, double-blind Phase 3 study to evaluate the efficacy, safety and tolerability of votoplam in participants with Huntington’s Disease.

Datos básicos

ENSAYO CLÍNICO Finan. Competitiva CHTT227A12301 HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE Año de incio: 2026

Documentos

  • No hay documentos

Participantes

Grupos

Financiadores - Promotores

NOVARTIS FARMACEUTICA, S.A.

Cita

Compartir